311 related articles for article (PubMed ID: 26424790)
1. Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2.
Dudakovic A; Camilleri ET; Xu F; Riester SM; McGee-Lawrence ME; Bradley EW; Paradise CR; Lewallen EA; Thaler R; Deyle DR; Larson AN; Lewallen DG; Dietz AB; Stein GS; Montecino MA; Westendorf JJ; van Wijnen AJ
J Biol Chem; 2015 Nov; 290(46):27604-17. PubMed ID: 26424790
[TBL] [Abstract][Full Text] [Related]
2. Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development.
Camilleri ET; Dudakovic A; Riester SM; Galeano-Garces C; Paradise CR; Bradley EW; McGee-Lawrence ME; Im HJ; Karperien M; Krych AJ; Westendorf JJ; Larson AN; van Wijnen AJ
J Biol Chem; 2018 Dec; 293(49):19001-19011. PubMed ID: 30327434
[No Abstract] [Full Text] [Related]
3. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells.
Wei Y; Chen YH; Li LY; Lang J; Yeh SP; Shi B; Yang CC; Yang JY; Lin CY; Lai CC; Hung MC
Nat Cell Biol; 2011 Jan; 13(1):87-94. PubMed ID: 21131960
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts.
Carrasco ME; Thaler R; Nardocci G; Dudakovic A; van Wijnen AJ
J Biol Chem; 2023 Sep; 299(9):105155. PubMed ID: 37572850
[TBL] [Abstract][Full Text] [Related]
5. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
Xu S; Xu Y; Yin M; Zhang S; Liu P; Koroleva M; Si S; Little PJ; Pelisek J; Jin ZG
Theranostics; 2018; 8(11):3007-3021. PubMed ID: 29896299
[No Abstract] [Full Text] [Related]
6. Chromatin dynamics and the role of G9a in gene regulation and enhancer silencing during early mouse development.
Zylicz JJ; Dietmann S; Günesdogan U; Hackett JA; Cougot D; Lee C; Surani MA
Elife; 2015 Nov; 4():. PubMed ID: 26551560
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific dual function: EZH2 regulates human erythropoiesis by eliciting histone and non-histone methylation.
Li M; Liu D; Xue F; Zhang H; Yang Q; Sun L; Qu X; Wu X; Zhao H; Liu J; Kang Q; Wang T; An X; Chen L
Haematologica; 2023 Sep; 108(9):2487-2502. PubMed ID: 37021526
[TBL] [Abstract][Full Text] [Related]
8. PRC2-independent chromatin compaction and transcriptional repression in cancer.
Vallot C; Hérault A; Boyle S; Bickmore WA; Radvanyi F
Oncogene; 2015 Feb; 34(6):741-51. PubMed ID: 24469045
[TBL] [Abstract][Full Text] [Related]
9. Role of EZH2 in adipogenesis and obesity: Current state of the art and implications - A review.
Wang H
Medicine (Baltimore); 2022 Sep; 101(36):e30344. PubMed ID: 36086687
[TBL] [Abstract][Full Text] [Related]
10. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
[TBL] [Abstract][Full Text] [Related]
11. MAPRE3 as an epigenetic target of EZH2 restricts ovarian cancer proliferation in vitro and in vivo.
Zhang Y; Liu F; Zheng J; Jiang K; Ai H; Liu L; Mao D
Exp Cell Res; 2024 Feb; 435(1):113913. PubMed ID: 38199479
[TBL] [Abstract][Full Text] [Related]
12. H3K27me3 is an Epigenetic Mark of Relevance in Endometriosis.
Colón-Caraballo M; Monteiro JB; Flores I
Reprod Sci; 2015 Sep; 22(9):1134-42. PubMed ID: 25820690
[TBL] [Abstract][Full Text] [Related]
13. CTR9 drives osteochondral lineage differentiation of human mesenchymal stem cells via epigenetic regulation of BMP-2 signaling.
Chan NT; Lee MS; Wang Y; Galipeau J; Li WJ; Xu W
Sci Adv; 2022 Nov; 8(46):eadc9222. PubMed ID: 36383652
[TBL] [Abstract][Full Text] [Related]
14. Neuronal Histone Methyltransferase EZH2 Regulates Neuronal Morphogenesis, Synaptic Plasticity, and Cognitive Behavior in Mice.
Zhang M; Zhang Y; Xu Q; Crawford J; Qian C; Wang GH; Qian J; Dong XZ; Pletnikov MV; Liu CM; Zhou FQ
Neurosci Bull; 2023 Oct; 39(10):1512-1532. PubMed ID: 37326884
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X Receptor Activation Alters the Chromatin Landscape To Commit Mesenchymal Stem Cells to the Adipose Lineage.
Shoucri BM; Martinez ES; Abreo TJ; Hung VT; Moosova Z; Shioda T; Blumberg B
Endocrinology; 2017 Oct; 158(10):3109-3125. PubMed ID: 28977589
[TBL] [Abstract][Full Text] [Related]
16. Novel insights of EZH2-mediated epigenetic modifications in degenerative musculoskeletal diseases.
Ma Z; Chen L; Wang Y; Zhang S; Zheng J; Luo Y; Wang C; Zeng H; Xue L; Tan Z; Wang D
Ageing Res Rev; 2023 Sep; 90():102034. PubMed ID: 37597667
[TBL] [Abstract][Full Text] [Related]
17. EZH2 can be used as a therapeutic agent for inhibiting endothelial dysfunction.
Sun L; Li X; Luo H; Guo H; Zhang J; Chen Z; Lin F; Zhao G
Biochem Pharmacol; 2023 Jul; 213():115594. PubMed ID: 37207700
[TBL] [Abstract][Full Text] [Related]
18. Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways.
Liu L; Xiao B; Hirukawa A; Smith HW; Zuo D; Sanguin-Gendreau V; McCaffrey L; Nam AJ; Muller WJ
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2303010120. PubMed ID: 37549258
[TBL] [Abstract][Full Text] [Related]
19. EZH2 in normal and malignant hematopoiesis.
Lund K; Adams PD; Copland M
Leukemia; 2014 Jan; 28(1):44-9. PubMed ID: 24097338
[TBL] [Abstract][Full Text] [Related]
20. G-protein coupled receptor 5C (GPRC5C) is required for osteoblast differentiation and responds to EZH2 inhibition and multiple osteogenic signals.
Dashti P; Thaler R; Hawse JR; Galvan ML; van der Eerden BJ; van Wijnen AJ; Dudakovic A
Bone; 2023 Nov; 176():116866. PubMed ID: 37558192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
